Connection

Ali Rizvi to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Ali Rizvi has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Rev Clin Pharmacol. 2019 Feb; 12(2):129-143.
    View in: PubMed
    Score: 0.137
  2. Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Metab Syndr Relat Disord. 2014 Feb; 12(1):1-10.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.